407 related articles for article (PubMed ID: 30552158)
1. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
[TBL] [Abstract][Full Text] [Related]
2. Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.
Delgado-Ramos GM; Nasir SS; Wang J; Schwartzberg LS
Breast Cancer Res Treat; 2020 Jul; 182(2):247-258. PubMed ID: 32447595
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.
Nyrop KA; Damone EM; Deal AM; Wheeler SB; Charlot M; Reeve BB; Basch E; Shachar SS; Carey LA; Reeder-Hayes KE; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Wood WA; Muss HB
Breast Cancer Res Treat; 2022 Jan; 191(2):409-422. PubMed ID: 34739658
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Autologous Breast Reconstruction Complications by Type of Neoadjuvant Chemotherapy Regimen.
Olawoyin OM; Mehta S; Chouairi F; Gabrick KS; Avraham T; Pusztai L; Alperovich M
Plast Reconstr Surg; 2021 Dec; 148(6):1186-1196. PubMed ID: 34644277
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
van Ramshorst MS; van der Voort A; van Werkhoven ED; Mandjes IA; Kemper I; Dezentjé VO; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS;
Lancet Oncol; 2018 Dec; 19(12):1630-1640. PubMed ID: 30413379
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
7. Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
Nyrop KA; Deal AM; Reeve BB; Basch E; Chen YT; Park JH; Shachar SS; Carey LA; Reeder-Hayes KE; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Lee JT; Wood WA; Muss HB
Cancer; 2020 Jul; 126(13):3084-3093. PubMed ID: 32315091
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study.
van Ramshorst MS; van Werkhoven E; Honkoop AH; Dezentjé VO; Oving IM; Mandjes IA; Kemper I; Smorenburg CH; Stouthard JM; Linn SC; Sonke GS;
Breast; 2016 Oct; 29():153-9. PubMed ID: 27498129
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
Wiranata JA; Hutajulu SH; Astari YK; Leo B; Bintoro BS; Hardianti MS; Taroeno-Hariadi KW; Kurnianda J; Purwanto I
PLoS One; 2024; 19(2):e0298928. PubMed ID: 38394281
[TBL] [Abstract][Full Text] [Related]
10. Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy.
Abdel-Rahman O
Breast Cancer; 2018 Nov; 25(6):723-728. PubMed ID: 29882200
[TBL] [Abstract][Full Text] [Related]
11. Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy.
Yang C; Li P; Chen Y; Zheng J; Zhang X; Gao HF; Zhang L; Wang K
Support Care Cancer; 2024 Jun; 32(6):401. PubMed ID: 38829506
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
13. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
14. [Current status and perspectives of chemotherapy for anthracycline-pretreated breast cancer].
Heinemann V
Onkologie; 2003 Dec; 26 Suppl 7():11-6. PubMed ID: 14716136
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
Nyrop KA; Deal AM; Chen YT; Reeve BB; Basch EM; Wood WA; Shachar SS; Carey LA; Reeder-Hayes KE; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Lee JT; Brenizer A; Muss HB
Cancer; 2021 Mar; 127(6):957-967. PubMed ID: 33216355
[TBL] [Abstract][Full Text] [Related]
16. Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.
van den Berg MMGA; Kok DE; Posthuma L; Kamps L; Kelfkens CS; Buist N; Geenen M; Haringhuizen A; Heijns JB; van Lieshout RHMA; Los M; Sommeijer DW; Timmer-Bonte JNH; de Kruif ATCM; van Laarhoven HWM; Kampman E; Winkels RM
Breast Cancer Res Treat; 2019 Jan; 173(2):475-481. PubMed ID: 30353244
[TBL] [Abstract][Full Text] [Related]
17. The influence of BRCA1/BRCA2 mutations on toxicity related to chemotherapy and radiotherapy in early breast cancer patients.
Huszno J; Budryk M; Kołosza Z; Nowara E
Oncology; 2013; 85(5):278-82. PubMed ID: 24217135
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.
Jasra S; Anampa J
Curr Treat Options Oncol; 2018 May; 19(6):30. PubMed ID: 29752560
[TBL] [Abstract][Full Text] [Related]
19. Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer.
Nyrop KA; Deal AM; Choi SK; Wagoner CW; Lee JT; Wood WA; Anders C; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Muss HB
Breast Cancer Res Treat; 2018 Feb; 168(1):43-55. PubMed ID: 29124455
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
